Papers
2
Total Citations
159
H-Index
2
About
J. A. Jenkins is a pioneering researcher in the field of ingestible biomedical devices, with a focus on robotic systems for gastrointestinal drug delivery and electrostimulation. Their work addresses critical challenges in oral drug administration, particularly for protein-based therapeutics that are typically degraded in the gastrointestinal tract. Jenkins’ most notable contribution, the "RoboCap" capsule (2022, 114 citations), introduces a robotic mucus-clearing mechanism that overcomes the steric and dynamic barrier of luminal mucus, enabling enhanced drug absorption and offering a non-invasive alternative to parenteral injections. This innovation has significant implications for treating conditions requiring protein drugs, such as diabetes or autoimmune disorders. Building on this, Jenkins developed an ingestible, battery-free, tissue-adhering robotic interface (2024, 45 citations) for chronic gut electrostimulation. This device improves electrode-tissue contact, navigation, and dwell time, addressing limitations of current ingestible electronics and opening avenues for non-invasive diagnosis and therapy. Jenkins’ work is characterized by its interdisciplinary approach, merging robotics, materials science, and gastroenterology. With a growing citation impact, their research is shaping the future of smart, ingestible technologies, earning recognition for advancing patient-friendly, long-term gastrointestinal interventions.
Research Focus
Key Achievements
Top Papers
- 1
- 2